Published in Blood on October 22, 2010
Histidine-rich glycoprotein uptake and turnover is mediated by mononuclear phagocytes. PLoS One (2014) 1.41
Proteomic analysis of human follicular fluid from fertile women. Clin Proteomics (2015) 0.91
Human plasma protein N-glycosylation. Glycoconj J (2015) 0.88
Histidine-rich glycoprotein binds fibrin(ogen) with high affinity and competes with thrombin for binding to the gamma'-chain. J Biol Chem (2011) 0.84
A gene-centric analysis of activated partial thromboplastin time and activated protein C resistance using the HumanCVD focused genotyping array. Eur J Hum Genet (2012) 0.82
Enhanced platelet activation mediates the accelerated angiogenic switch in mice lacking histidine-rich glycoprotein. PLoS One (2011) 0.81
Arterial thrombosis is accelerated in mice deficient in histidine-rich glycoprotein. Blood (2015) 0.78
Plasma proteome analysis on cynomolgus monkey (Macaca fascicularis) pedigrees with early onset drusen formation. Exp Anim (2014) 0.77
Specific Gene Loci of Clinical Pseudomonas putida Isolates. PLoS One (2016) 0.76
Plasma free fatty acid levels influence Zn(2+) -dependent histidine-rich glycoprotein-heparin interactions via an allosteric switch on serum albumin. J Thromb Haemost (2014) 0.76
Histidine-Rich Glycoprotein Prevents Septic Lethality through Regulation of Immunothrombosis and Inflammation. EBioMedicine (2016) 0.76
The histidine-rich glycoprotein A1042G polymorphism and recurrent miscarriage: a pilot study. Reprod Biol Endocrinol (2014) 0.75
Functional Regulation of the Plasma Protein Histidine-Rich Glycoprotein by Zn(2+) in Settings of Tissue Injury. Biomolecules (2017) 0.75
(18) O proteomics reveal increased human apolipoprotein CIII in Hispanic HIV-1+ women with HAART that use cocaine. Proteomics Clin Appl (2015) 0.75
Purification of rabbit serum histidine-proline-rich glycoprotein via preparative gel electrophoresis and characterization of its glycosylation patterns. PLoS One (2017) 0.75
The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity (2009) 7.69
Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat Protoc (2007) 3.45
DNAzyme targeting c-jun suppresses skin cancer growth. Sci Transl Med (2012) 3.09
Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma. Proteomics (2013) 1.93
Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo. Breast Cancer Res Treat (2009) 1.69
Heparan sulfate and heparanase play key roles in mouse β cell survival and autoimmune diabetes. J Clin Invest (2011) 1.47
A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer. Oncogene (2005) 1.43
Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance. J Immunol (2007) 1.36
Histidine-rich glycoprotein: A novel adaptor protein in plasma that modulates the immune, vascular and coagulation systems. Immunol Cell Biol (2005) 1.32
New and improved methods for measuring lymphocyte proliferation in vitro and in vivo using CFSE-like fluorescent dyes. J Immunol Methods (2012) 1.32
Dynamic histone variant exchange accompanies gene induction in T cells. Mol Cell Biol (2009) 1.31
Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy. Cancer Res (2004) 1.21
Chromatin-associated protein kinase C-θ regulates an inducible gene expression program and microRNAs in human T lymphocytes. Mol Cell (2011) 1.15
The use of carboxyfluorescein diacetate succinimidyl ester (CFSE) to monitor lymphocyte proliferation. J Vis Exp (2010) 1.14
Phosphoinositide-mediated oligomerization of a defensin induces cell lysis. Elife (2014) 1.11
Phosphomannopentaose sulfate (PI-88): heparan sulfate mimetic with clinical potential in multiple vascular pathologies. Cardiovasc Drug Rev (2004) 1.10
Interplay between chromatin remodeling and epigenetic changes during lineage-specific commitment to granzyme B expression. J Immunol (2009) 1.09
Bystander B cells rapidly acquire antigen receptors from activated B cells by membrane transfer. Proc Natl Acad Sci U S A (2008) 1.07
Perceptions in health and medical research careers: the Australian Society for Medical Research Workforce Survey. Med J Aust (2008) 1.06
The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus. Antiviral Res (2004) 1.05
Dramatic regulation of heparanase activity and angiogenesis gene expression in synovium from patients with rheumatoid arthritis. Arthritis Rheum (2008) 1.03
Eotaxin selectively binds heparin. An interaction that protects eotaxin from proteolysis and potentiates chemotactic activity in vivo. J Biol Chem (2007) 1.02
Early growth response gene 1 (EGR1) regulates heparanase gene transcription in tumor cells. J Biol Chem (2005) 1.02
Regulation of inducible heparanase gene transcription in activated T cells by early growth response 1. J Biol Chem (2003) 0.97
New insights into intracellular locations and functions of heme oxygenase-1. Antioxid Redox Signal (2014) 0.97
Cell surface-expressed cation-independent mannose 6-phosphate receptor (CD222) binds enzymatically active heparanase independently of mannose 6-phosphate to promote extracellular matrix degradation. J Biol Chem (2007) 0.96
Dimerization of plant defensin NaD1 enhances its antifungal activity. J Biol Chem (2012) 0.96
A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis. J Am Soc Nephrol (2004) 0.93
Heparan sulfate and inflammation. Nat Immunol (2005) 0.92
Platelets and P-selectin control tumor cell metastasis in an organ-specific manner and independently of NK cells. Cancer Res (2012) 0.92
Targeted liposomal delivery of TLR9 ligands activates spontaneous antitumor immunity in an autochthonous cancer model. J Immunol (2009) 0.91
Comment on: Korpos et al. The peri-islet basement membrane, a barrier to infiltrating leukocytes in type 1 diabetes in mouse and human. Diabetes 2013;62:531-542. Diabetes (2013) 0.91
Histidine-rich glycoprotein binds to cell-surface heparan sulfate via its N-terminal domain following Zn2+ chelation. J Biol Chem (2004) 0.91
Use of sulfated linked cyclitols as heparan sulfate mimetics to probe the heparin/heparan sulfate binding specificity of proteins. J Biol Chem (2005) 0.90
Liposomal vaccines--targeting the delivery of antigen. Methods (2006) 0.90
The endoglycosidase heparanase enters the nucleus of T lymphocytes and modulates H3 methylation at actively transcribed genes via the interplay with key chromatin modifying enzymes. Transcription (2012) 0.89
Computational analyses of the catalytic and heparin-binding sites and their interactions with glycosaminoglycans in glycoside hydrolase family 79 endo-β-D-glucuronidase (heparanase). Glycobiology (2011) 0.89
Mice deficient in heparanase exhibit impaired dendritic cell migration and reduced airway inflammation. Eur J Immunol (2014) 0.87
Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1. J Leukoc Biol (2007) 0.87
Evidence that the cellular ligand for the human NK cell activation receptor NKp30 is not a heparan sulfate glycosaminoglycan. J Immunol (2005) 0.86
Histidine-rich glycoprotein is a novel plasma pattern recognition molecule that recruits IgG to facilitate necrotic cell clearance via FcgammaRI on phagocytes. Blood (2010) 0.86
Fluorescent target array killing assay: a multiplex cytotoxic T-cell assay to measure detailed T-cell antigen specificity and avidity in vivo. Cytometry A (2012) 0.85
Extracellular matrix components in the pathogenesis of type 1 diabetes. Curr Diab Rep (2014) 0.85
T cell receptor sharing by cytotoxic T lymphocytes facilitates efficient virus control. Proc Natl Acad Sci U S A (2009) 0.84
The yeast homolog of heme oxygenase-1 affords cellular antioxidant protection via the transcriptional regulation of known antioxidant genes. J Biol Chem (2010) 0.84
A one-pot synthesis and biological activity of ageladine A and analogues. J Med Chem (2011) 0.84
The accumulation of circulating histones on heparan sulphate in the capillary glycocalyx of the lungs. Biomaterials (2013) 0.84
Histidine-rich glycoprotein functions cooperatively with cell surface heparan sulfate on phagocytes to promote necrotic cell uptake. J Leukoc Biol (2010) 0.83
Heparanase in primary human osteoblasts. J Orthop Res (2010) 0.83
Inhibition of Plasmodium falciparum growth in vitro and adhesion to chondroitin-4-sulfate by the heparan sulfate mimetic PI-88 and other sulfated oligosaccharides. Antimicrob Agents Chemother (2006) 0.83
Yin Yang-1 inhibits tumor cell growth and inhibits p21WAF1/Cip1 complex formation with cdk4 and cyclin D1. Int J Oncol (2012) 0.83
Plasminogen is tethered with high affinity to the cell surface by the plasma protein, histidine-rich glycoprotein. J Biol Chem (2004) 0.82
Recombinant expression and purification of the tomato defensin TPP3 and its preliminary X-ray crystallographic analysis. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.82
A novel fluorescent-based assay reveals that thrombopoietin signaling and Bcl-X(L) influence, respectively, platelet and erythrocyte lifespans. Exp Hematol (2010) 0.82
Heparanase and vascular endothelial growth factor expression is increased in hypoxia-induced retinal neovascularization. Invest Ophthalmol Vis Sci (2012) 0.81
Alternatively activated macrophage possess antitumor cytotoxicity that is induced by IL-4 and mediated by arginase-1. J Immunother (2010) 0.81
Nuclear import of early growth response-1 involves importin-7 and the novel nuclear localization signal serine-proline-serine. Int J Biochem Cell Biol (2011) 0.81
Histidine-rich glycoprotein specifically binds to necrotic cells via its amino-terminal domain and facilitates necrotic cell phagocytosis. J Biol Chem (2005) 0.81
Regulation of histidine-rich glycoprotein (HRG) function via plasmin-mediated proteolytic cleavage. Biochem J (2009) 0.81
Targeting dendritic cells with antigen-containing liposomes: antitumour immunity. Expert Opin Biol Ther (2004) 0.81
Activation of cathepsin D by glycosaminoglycans. FEBS J (2009) 0.81
C8c-C15 monoseco-analogues of the phenanthroquinolizidine alkaloids julandine and cryptopleurine exhibiting potent anti-angiogenic properties. Bioorg Med Chem Lett (2005) 0.80
Fluorescent target array T helper assay: a multiplex flow cytometry assay to measure antigen-specific CD4+ T cell-mediated B cell help in vivo. J Immunol Methods (2012) 0.80
Histidine-rich glycoprotein binds heparanase and regulates its enzymatic activity and cell surface interactions. Int J Biochem Cell Biol (2010) 0.79
Reduced retinal microvascular density, improved forepaw reach, comparative microarray and gene set enrichment analysis with c-jun targeting DNA enzyme. PLoS One (2012) 0.78
Human mast cell line-1 (HMC-1) cells transfected with FcεRIα are sensitive to IgE/antigen-mediated stimulation demonstrating selectivity towards cytokine production. Int Immunopharmacol (2011) 0.78
New method for purifying histidine-rich glycoprotein from human plasma redefines its functional properties. IUBMB Life (2013) 0.77
Activation of tumour cell ECM degradation by thrombin-activated platelet membranes: potentially a P-selectin and GPIIb/IIIa-dependent process. Clin Exp Metastasis (2015) 0.77
The antiangiogenic properties of sulfated β-cyclodextrins in anticancer formulations incorporating 5-fluorouracil. Anticancer Drugs (2013) 0.77
Regulation of mouse Heparanase gene expression in T lymphocytes and tumor cells. Immunol Cell Biol (2007) 0.76
Crystallization and preliminary X-ray crystallographic analysis of the plant defensin NaD1. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.76
Mutagenesis within human FcepsilonRIalpha differentially affects human and murine IgE binding. J Immunol (2002) 0.76
Immunology and Cell Biology Publication of the Year Award 2008. Immunol Cell Biol (2009) 0.75
Destroying c-jun Messenger: new insights into biological mechanisms of DNAzyme function. Oncotarget (2012) 0.75
Convergent synthesis and preliminary biological evaluations of the stilbenolignan (+/-)-aiphanol and various congeners. Org Biomol Chem (2003) 0.75
Immunology and cell biology publication of the year award 2009. Immunol Cell Biol (2010) 0.75
Transition Metal Doping Reveals Link Between Electron T1 Reduction and (13)C Dynamic Nuclear Polarization Efficiency. J Phys Chem A (2017) 0.75